 |
 |
Article dans une revue
Apelin treatment increases complete Fatty Acid oxidation, mitochondrial oxidative capacity, and biogenesis in muscle of insulin-resistant mice.
Abstract : Both acute and chronic apelin treatment have been shown to improve insulin sensitivity in mice. However, the effects of apelin on fatty acid oxidation (FAO) during obesity-related insulin resistance have not yet been addressed. Thus, the aim of the current study was to determine the impact of chronic treatment on lipid use, especially in skeletal muscles. High-fat diet (HFD)-induced obese and insulin-resistant mice treated by an apelin injection (0.1 μmol/kg/day i.p.) during 4 weeks had decreased fat mass, glycemia, and plasma levels of triglycerides and were protected from hyperinsulinemia compared with HFD PBS-treated mice. Indirect calorimetry experiments showed that apelin-treated mice had a better use of lipids. The complete FAO, the oxidative capacity, and mitochondrial biogenesis were increased in soleus of apelin-treated mice. The action of apelin was AMP-activated protein kinase (AMPK) dependent since all the effects studied were abrogated in HFD apelin-treated mice with muscle-specific inactive AMPK. Finally, the apelin-stimulated improvement of oxidative capacity led to decreased levels of acylcarnitines and enhanced insulin-stimulated glucose uptake in soleus. Thus, by promoting complete lipid use in muscle of insulin-resistant mice through mitochondrial biogenesis and tighter matching between FAO and the tricarboxylic acid cycle, apelin treatment could contribute to insulin sensitivity improvement.
Littérature citée [40 références]
https://hal-univ-bourgogne.archives-ouvertes.fr/hal-00723095
Contributeur : Sabine Julien Connectez-vous pour contacter le contributeur
Soumis le : vendredi 29 mai 2020 - 03:52:57
Dernière modification le : vendredi 11 février 2022 - 15:40:05
Contributeur : Sabine Julien Connectez-vous pour contacter le contributeur
Soumis le : vendredi 29 mai 2020 - 03:52:57
Dernière modification le : vendredi 11 février 2022 - 15:40:05
Fichier
attane_2012_vol61_pp310_diabet...
Fichiers éditeurs autorisés sur une archive ouverte
Licence
Distributed under a Creative Commons Paternité - Pas d'utilisation commerciale - Pas de modification 4.0 International License